Psoriasis Induced by Trastuzumab (Herceptin®)

Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dae Hun, Jeong, Nam Ji, Im, Myung, Lee, Young, Seo, Young Joon, Lee, Jeung Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662920/
https://www.ncbi.nlm.nih.gov/pubmed/23717018
http://dx.doi.org/10.5021/ad.2013.25.2.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662920/
https://www.ncbi.nlm.nih.gov/pubmed/23717018
http://dx.doi.org/10.5021/ad.2013.25.2.229

Ejemplares similares